Novyra Pharmachem Limited Share Price History
NOVYRA PHARMACHEM LIMITED
BSE : 13 Nov, 2026
7.35-0.3 (-4.3%)
Prev Close
7.7
Open Price
8.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
1100
Today's High / Low
8.1 / 7.3
52 WK High / Low
16.5 / 7.3
Market Price of NOVYRA PHARMACHEM LIMITED
1M
1Y
3Y
5Y
Monitoring NOVYRA PHARMACHEM LIMITED share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 2 |
| Sales YoY Gr. | - |
| Adj EPS | 0.04 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 9.97 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 0.81 |
| Op. Profit Mgn % | 6 |
| Net Profit Mgn % | 1.33 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About NOVYRA PHARMACHEM LIMITED
- Bansisons Tea Industries Limited was incorporated on September 8, 1987 with the Registrar of Companies, West Bengal.
- Subsequently, Company changed its name to 'Essel Tea Exports Limited' dated May 19, 1992 and further the name of the Company was changed to 'Bansisons Tea Industries Limited' pursuant to fresh Certificate of incorporation issued by the ROC, West Bengal dated October 12, 1995.
- The change in name of the Company has been effected on January 19, 2026 to 'Novyra Pharmachem Limited' through postal ballot notice. Company is among the India's oldest tea brand from the land where the finest tea in the world is grown, Darjeeling.
- Established in 1987, it has well established brand and plants.
- Initially, the Company concentrated its main activities in increasing the tea plantation, maintenance of tea bushes and tea manufacturing.
Popular Search
FAQs for NOVYRA PHARMACHEM LIMITED Share Price History
What are the key events that typically impact NOVYRA PHARMACHEM LIMITED's share price history?
Key events that impact NOVYRA PHARMACHEM LIMITED’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect NOVYRA PHARMACHEM LIMITED's share price history?
Stock splits reduce the nominal price of NOVYRA PHARMACHEM LIMITED's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of NOVYRA PHARMACHEM LIMITED?
Dividends can influence NOVYRA PHARMACHEM LIMITED's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect NOVYRA PHARMACHEM LIMITED’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on NOVYRA PHARMACHEM LIMITED generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand NOVYRA PHARMACHEM LIMITED’s share price history?
To understand NOVYRA PHARMACHEM LIMITED’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
